Amyloid β Protein Monoclonal Antibody

Code No: M046-3
Datasheet: 
FID:5527 | PATH:sites/default/files/datasheets/M046-3.PDF
Target: 

Amyloid Beta-Protein

Background: 

Alzheimer�s disease (AD) is the most common form of dementia in the elderly. The neuropathological hallmarks are neurofibrillary tangles and senile plaques. The major protein component of the plaques is a 39-42 amino acid peptide (?-amyloid/A?). A? occurs in two predominant forms with different COOH-termini, A? 40 and A? 42, and overproduction of A? 42 has been suggested to be the cause of familial early-onset AD. A? generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: ?-secretase and ?-secretase. Recent study suggested that a transmembrane aspartic protease, termed beta-site APP-cleaving enzyme (BACE), functionally acts as the ?-secretase. This antibody recognizes N-terminal of A? 40 and A? 42 specifically.

Size: 
100 ?g
Application: 
WB
Application: 
IHC
Clone Number: 
2C8
Concentration: 
1 mg/mL
Product Type: 
Primary Antibody
Species Reactivities: 
Human
Isotype: 
IgG2b
Storage Temp. (°C): 
4
Shipping Temp. (°C): 
4
References: 

1) Saito, A., at al, Proc. Natl. Acad. Sci. USA, 9, 9725-9729 (1994)
2) Bergamaschihi, L., et al, Clin. Exp. Immunol. 115, 526-533 (1999)
3) Vassar R., et al, Science 286, 735-741 (1999).

Formulation: 
100 ug IgG in 100 uL volume of PBS containing 50% glycerol, pH 7.2. Contains no preservatives.
Reactivity: 
This antibody reacts with synthetic ?- amyloid (1-40) and (1-42) on Western blotting. This antibody does not react with recombinant APP (601-744). Thus this antibody thought to recognize N-terminal of A? (40) and A? (42) specifically.
Intended Use: 
For Research use only. Not for use in diagnostic procedure.